Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Gallagher, Ruairi M ^a   Kirkham, Jamie J ^a   Mason, Jennifer R ^b   Bird, Kim A ^b   Williamson, Paula R ^a   Nunn, Anthony J ^b   Turner, Mark A ^a   Smyth, Rosalind L ^a   Pirmohamed, Munir ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CAUSALITY CATEGORY; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; KAPPA STATISTICS; LIVERPOOL ADVERSE DRUG REACTION CAUSALITY ASSESSMENT TOOL; MEASURE OF DISAGREEMENT; NARANJO ADVERSE DRUG REACTION CAUSALITY ASSESSMENT TOOL; OBSERVATIONAL STUDY; QUESTIONNAIRE; STATISTICAL PARAMETERS; VALIDITY; DECISION MAKING; DRUG SURVEILLANCE PROGRAM; EPIDEMIOLOGY; HUMAN; OBSERVER VARIATION; REPRODUCIBILITY; STANDARD;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CAUSALITY; DECISION MAKING; HUMANS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS;

EID: 83355170778     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028096     Document Type: Article

References (26)

1. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, et al. (2001) Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. British Journal Of Clinical Pharmacology 52: 77-83.
2. Clavenna A, Bonati M, (2009) Adverse drug reactions in childhood: a review of prospective studies and safety alerts. Arch Dis Child 94: 724-728.
3. Agbabiaka TB, Savovic J, Ernst E, (2008) Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf 31: 21-37.
4. Turner WM, (1984) The Food and Drug Administration algorithm. Special workshop-regulatory. Drug Information Journal 18: 259-266.
5. Arimone Y, Bidault I, Collignon AE, Dutertre JP, Gerardin M, et al. (2010) Updating of the French causality assessment method: 29. Fundamental & Clinical Pharmacology 6.
6. Laine L, Goldkind L, Curtis SP, Connors LG, Zhang YQ, et al. (2009) How Common Is Diclofenac-Associated Liver Injury? Analysis of 17,289 Arthritis Patients in a Long-Term Prospective Clinical Trial. American Journal Of Gastroenterology 104: 356-362.
7. Kling A, (2004) Sepsis as a possible adverse drug reaction in patients with rheumatoid arthritis treated with TNFalpha antagonists. JCR: Journal of Clinical Rheumatology 10: 119-122.
8. Macedo AF, Marques FB, Ribeiro CF, Teixeira F, (2005) Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf 14: 885-890.
9. Hill AB, (1965) THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med pp. 295-300.
10. Naranjo CA, Busto U, Sellers EM, (1981) A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and Therapeutics 30: 239-245.
11. Irey NS, (1976) Tissue reactions to drugs. American Journal of Pathology 82: 613-648.
12. Arimone Y, Begaud B, Miremont-Salame G, Fourrier-Reglat A, Moore N, et al. (2005) Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol 61: 169-173.
13. Jones JK, (2005) Determining causation from case reports. Pharmacoepidemiology/edited by Brian L. Strom; In: Strom BL, editors. J. Wiley: Chichester, England.
14. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, et al. (2009) Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes. PLOS ONE 4.
15. Pirmohamed M, James S, Meakin S, Green C, Scott AK, et al. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. British Medical Journal 329: 15-19.
16. Avner M, Finkelstein Y, Hackam D, Koren G, (2007) Establishing causality in pediatric adverse drug reactions: use of the Naranjo probability scale. Paediatr Drugs 9: 267-270.
17. Kane-Gill SL, (2005) Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit? Annals Of Pharmacotherapy 39: 1823-1827.
18. Garcia-Cortes M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, et al. (2008) Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury. Alimentary Pharmacology & Therapeutics 27: 780-789.
19. Fleiss JL, (1971) Measuring nominal scale agreement among many raters. Psychological Bulletin 76: 378-382.
20. Altman DG, (1991) Practical statistics for medical research London Chapman & Hall.
21. University of Liverpool (2009) Adverse drug reactions in children. Available at: http://www.adric.org.uk/. Accessed 2011 March 1.
22. Feinstein AR, Cicchetti DV, (1990) High agreement but low kappa: I. The problems of two paradoxes. Journal of Clinical Epidemiology 43: 543-549.
23. Cicchetti DV, Feinstein AR, (1990) High agreement but low kappa: II. Resolving the paradoxes. Journal of Clinical Epidemiology 43: 551-558.
24. Lantz CA, Nebenzahl E, (1996) Behavior and interpretation of the kappa statistic: resolution of the two paradoxes. Journal of Clinical Epidemiology 49: 431-434.
25. Danan G, Benichou C, (1993) Causality Assessment of Adverse Reactions to Drugs.1. A Novel Method Based on the Conclusions of International Consensus Meetings- Application to Drug-Induced Liver Injuries. Journal of Clinical Epidemiology 46: 1323-1330.
26. Koh Y, Li SC, (2005) A new algorithm to identify the causality of adverse drug reactions. Drug Saf 28: 1159-1161.